The answer so far
Some early experiments made oxytocin look promising for social behaviour, but later findings are mixed. A larger registered trust-game replication did not confirm a simple general effect, and a large trial in autistic children found no significant benefit on its measured social or cognitive outcomes. Neither result proves what happens in every situation or validates a retail spray.235
On this page
Why did researchers look at a spray?
Oxytocin is involved in signalling in the brain as well as in childbirth and milk release. Researchers wanted to test whether administering it could alter particular social behaviours. That is a question to investigate, not a guarantee that more oxytocin produces closeness. Start with what oxytocin does in the body.12
What did the original trust experiment find?
In 2005, researchers reported that men given intranasal oxytocin made more trusting choices in a laboratory investment game than those given placebo. The game gave researchers a specific behaviour to compare under controlled conditions. It did not measure whether participants formed stronger friendships, became better partners or experienced lasting relief from anxiety.2
Did a larger replication get the same answer?
A 2020 registered replication involved 321 participants and compared social-contact conditions in a trust game. Its planned analyses did not support a simple, general increase in trust from oxytocin. An exploratory finding in a subgroup needs independent confirmation. The original result and the replication do not answer every conceivable social question, but together make a universal “trust spray” claim difficult to support. In 2026, another registered replication added 211 participants and combined its data with the 2020 study: the pooled group of 532 did not show a meaningful trust-game effect. These are laboratory decisions, not every form of social connection.327
What did trials with autistic children show?
A four-week 2017 pilot in 32 autistic children reported a positive result on a social-responsiveness measure in an analysis accounting for pre-treatment hormone levels; without that adjustment, the group difference was not statistically significant. In contrast, a 2021 randomised trial enrolled 290 autistic children and adolescents aged 3–17 for 24 weeks. On its main social-withdrawal scale, the adjusted average change was −3.7 points with oxytocin and −3.5 with placebo; the difference was not statistically significant. Secondary social and cognitive measures generally did not differ. These are findings about specified measurements in those trials, not judgments about autistic identity or what support an individual may want.45
What about safety and products sold online?
In the 24-week trial, the incidence and severity of adverse events were similar between groups; that does not establish safety with longer use, different populations or a different formulation. A research preparation, an online product and a hospital injection may differ in quality, concentration and route. The US Pitocin injection label describes meaningful obstetric risks and supervision requirements; it is not a safety label for a nasal spray. Ask a clinician or pharmacist about a particular product, especially during pregnancy or breastfeeding.56
What should I make of a bold claim?
Look for a trial in people like those the claim concerns, with the same product and an outcome that matters to them. A change in a game, brain signal or questionnaire is not automatically proof of better relationships or lasting relief. Compare another claimed approach in the Selank anxiety studies; the peptides and their evidence are different. For the broader question, explore stress, mood and support.35
Sources, kept close.
Selected supporting sources; this is not a complete literature review.
- OxytocinSociety for Endocrinology · Professional society physiology explainer
- Oxytocin increases trust in humansNature / PubMed · Randomised laboratory study
- A registered replication study on oxytocin and trustNature Human Behaviour · Registered randomised replication
- Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autismProceedings of the National Academy of Sciences / PubMed · Randomised placebo-controlled pilot
- Intranasal Oxytocin in Children and Adolescents with Autism Spectrum DisorderNew England Journal of Medicine / PubMed · Randomised placebo-controlled clinical trial
- Pitocin (oxytocin injection): US prescribing informationPar Health USA / US National Library of Medicine DailyMed · Manufacturer prescribing information
- Absence of a meaningful effect of intranasal oxytocin on trusting behavior: a registered report with pooled equivalence testingCortex / PubMed · Registered replication and pooled analysis